Cronos (CRON) Net Margin (2019 - 2026)
Cronos (CRON) posted quarterly Net Margin of 34.75% for Q1 2026, down 4540.0% year-over-year from 0.78% in Q1 2025, and up 3251.74% quarter-over-quarter from 1.1% in Q4 2025.
Cronos (CRON) Net Margin (2019 - 2026) Analysis & Trends
Cronos' Net Margin history runs 7 years deep, the most recent figure standing at 34.75% for Q1 2026.
- In Q1 2026, Net Margin fell 4540.0% year-over-year to 34.75%; the TTM figure through Mar 2026 stood at 3.39% (down 1002.0% YoY), while the FY2023 annual figure was 4.72%, up 5539.0% from the prior year.
- Net Margin for Q1 2026 stood at 34.75%, up from 1.1% in the prior quarter.
- The five-year high for Net Margin was 80.15% in Q1 2025, with the low at 356.41% in Q2 2025.
- The 4-year median for Net Margin is 0.92% (2023), against an average of 19.64%.
- The sharpest annual moves came in 2022 and 2026: Net Margin jumped 415884 bps in 2022, then tumbled 4540 bps in 2026.
- Cronos' Net Margin stood at 6.35% in 2022, then sank by 92 bps to 0.52% in 2023, then slumped by 313 bps to 1.1% in 2025, then soared by 3252 bps to 34.75% in 2026.
- Business Quant data shows CRON's Net Margin at 34.75% in Q1 2026, 1.1% in Q4 2025, and 58.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 50.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.52% |
| Mar 31, 2026 | 34.75% |
| Dec 31, 2025 | -1.10% |
| Sep 30, 2025 | 58.00% |
| Jun 30, 2025 | -356.41% |
| Mar 31, 2025 | 80.15% |
| Dec 31, 2023 | 0.52% |
| Sep 30, 2023 | -0.73% |
| Jun 30, 2023 | -10.99% |
| Mar 31, 2023 | -17.31% |
| Dec 31, 2022 | 6.35% |
| Sep 30, 2022 | -18.53% |
| Jun 30, 2022 | -10.37% |
| Dec 31, 2021 | -4,152.50% |
| Sep 30, 2021 | 1.96% |
| Jun 30, 2021 | -3.59% |
| Mar 31, 2021 | -0.17% |
| Dec 31, 2020 | -1.06% |
| Sep 30, 2020 | -4.16% |
| Jun 30, 2020 | -0.47% |